Sirona Biochem Corp. (SRBCF)
USD 0.05
(0.0%)
USD 0.05
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.01 CAD | 31.76% |
| 2022 | -0.01 CAD | -46.53% |
| 2021 | -0.01 CAD | 44.81% |
| 2020 | -0.02 CAD | 19.03% |
| 2019 | -0.02 CAD | -205.41% |
| 2018 | -0.01 CAD | 73.57% |
| 2017 | -0.03 CAD | -49.73% |
| 2016 | -0.02 CAD | 26.95% |
| 2015 | -0.03 CAD | 14.38% |
| 2014 | -0.03 CAD | 0.99% |
| 2013 | -0.03 CAD | 25.06% |
| 2012 | -0.04 CAD | 12.96% |
| 2011 | -0.05 CAD | -14.32% |
| 2010 | -0.04 CAD | 26.9% |
| 2009 | -0.06 CAD | -346.77% |
| 2008 | -0.01 CAD | 84.24% |
| 2007 | -0.08 CAD | 0.0% |
| 2006 | - CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.00 CAD | 44.83% |
| 2024 Q1 | -0.00 CAD | -16.0% |
| 2024 Q3 | -0.00 CAD | -112.5% |
| 2023 Q2 | -0.00 CAD | -20.0% |
| 2023 FY | - CAD | 31.76% |
| 2023 Q1 | -0.00 CAD | -78.57% |
| 2023 Q4 | -0.00 CAD | -19.05% |
| 2023 Q3 | -0.00 CAD | 30.0% |
| 2022 Q4 | -0.00 CAD | 6.67% |
| 2022 Q3 | -0.00 CAD | 55.88% |
| 2022 FY | - CAD | -46.53% |
| 2022 Q1 | -0.01 CAD | -584.62% |
| 2022 Q2 | -0.00 CAD | 61.8% |
| 2021 Q1 | -0.00 CAD | -66.67% |
| 2021 FY | - CAD | 44.81% |
| 2021 Q2 | -0.00 CAD | -23.33% |
| 2021 Q4 | -0.00 CAD | 77.97% |
| 2021 Q3 | -0.01 CAD | -59.46% |
| 2020 Q3 | -0.01 CAD | -96.3% |
| 2020 Q4 | -0.00 CAD | 66.04% |
| 2020 Q2 | -0.00 CAD | 68.24% |
| 2020 Q1 | -0.01 CAD | -49.12% |
| 2020 FY | - CAD | 19.03% |
| 2019 Q2 | -0.01 CAD | -109.38% |
| 2019 Q3 | -0.01 CAD | 0.0% |
| 2019 FY | - CAD | -205.41% |
| 2019 Q4 | -0.01 CAD | 14.93% |
| 2019 Q1 | -0.00 CAD | 13.51% |
| 2018 FY | - CAD | 73.57% |
| 2018 Q4 | -0.00 CAD | -716.67% |
| 2018 Q1 | -0.00 CAD | 96.09% |
| 2018 Q2 | -0.00 CAD | -414.29% |
| 2018 Q3 | 0.00 CAD | 116.67% |
| 2017 FY | - CAD | -49.73% |
| 2017 Q3 | -0.00 CAD | 9.52% |
| 2017 Q2 | -0.00 CAD | -20.0% |
| 2017 Q1 | -0.00 CAD | 35.19% |
| 2017 Q4 | -0.02 CAD | -371.05% |
| 2016 Q2 | -0.00 CAD | 52.94% |
| 2016 Q4 | -0.01 CAD | 5.26% |
| 2016 Q3 | -0.01 CAD | -137.5% |
| 2016 FY | - CAD | 26.95% |
| 2016 Q1 | -0.01 CAD | -24.39% |
| 2015 FY | - CAD | 14.38% |
| 2015 Q1 | -0.01 CAD | -92.68% |
| 2015 Q4 | -0.00 CAD | 46.75% |
| 2015 Q3 | -0.01 CAD | -14.93% |
| 2015 Q2 | -0.01 CAD | 15.19% |
| 2014 FY | - CAD | 0.99% |
| 2014 Q4 | -0.00 CAD | 28.07% |
| 2014 Q3 | -0.01 CAD | 50.0% |
| 2014 Q2 | -0.01 CAD | -22.58% |
| 2014 Q1 | -0.01 CAD | -30.99% |
| 2013 Q4 | -0.01 CAD | -18.33% |
| 2013 FY | - CAD | 25.06% |
| 2013 Q2 | -0.01 CAD | 11.11% |
| 2013 Q1 | -0.01 CAD | 0.0% |
| 2013 Q3 | -0.01 CAD | 25.0% |
| 2012 Q3 | -0.00 CAD | 56.48% |
| 2012 Q2 | -0.01 CAD | -31.71% |
| 2012 FY | - CAD | 12.96% |
| 2012 Q1 | -0.01 CAD | 0.0% |
| 2012 Q4 | - CAD | 100.0% |
| 2011 Q2 | -0.01 CAD | 46.79% |
| 2011 Q3 | -0.01 CAD | 0.0% |
| 2011 Q1 | -0.02 CAD | 0.0% |
| 2011 FY | - CAD | -14.32% |
| 2011 Q4 | - CAD | 100.0% |
| 2010 Q1 | -0.01 CAD | 0.0% |
| 2010 Q4 | - CAD | 100.0% |
| 2010 Q2 | -0.01 CAD | 23.91% |
| 2010 Q3 | -0.01 CAD | -14.29% |
| 2010 FY | - CAD | 26.9% |
| 2009 Q2 | -0.03 CAD | -810.53% |
| 2009 Q3 | -0.01 CAD | 76.59% |
| 2009 FY | - CAD | -346.77% |
| 2009 Q4 | - CAD | 100.0% |
| 2009 Q1 | -0.00 CAD | 0.0% |
| 2008 Q4 | - CAD | 100.0% |
| 2008 Q3 | -0.00 CAD | 57.78% |
| 2008 FY | - CAD | 84.24% |
| 2008 Q1 | -0.00 CAD | 0.0% |
| 2008 Q2 | -0.00 CAD | -150.0% |
| 2007 FY | - CAD | 0.0% |
| 2007 Q3 | -0.00 CAD | 71.67% |
| 2007 Q1 | -0.03 CAD | 0.0% |
| 2007 Q4 | - CAD | 100.0% |
| 2007 Q2 | -0.01 CAD | 76.1% |
| 2006 FY | - CAD | 0.0% |